VKORC1 variants as significant predictors of warfarin dose in Emiratis

References

• Johnson JA, Cavallari LH. Warfarin pharmacogenetics. Trends Cardiovasc Med. 2015;25:33–41. doi:10.1016/j.tcm.2014.09.00125282448
   PubMed Web of Science ®Google Scholar
• Kawai VK, Cunningham A, Vear SI, et al. Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics. 2014;15:1973–1983. doi:10.2217/pgs.14.15325521356
   PubMed Web of Science ®Google Scholar
• Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128:1300–1305.e1302. doi:10.1016/j.amjmed.2015.05.04426144101
   PubMed Web of Science ®Google Scholar
• Johnson JA, Gong L, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011;90:625–629. doi:10.1038/clpt.2011.18521900891
   PubMed Web of Science ®Google Scholar
• Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5:615–621. doi:10.1161/CIRCOUTCOMES.112.96729922949490
   PubMed Web of Science ®Google Scholar
• Bista D, Chalmers L, Bereznicki L, Peterson G. Potential use of NOACs in developing countries: pros and cons. Eur J Clin Pharmacol. 2014;70:817–828. doi:10.1007/s00228-014-1693-y24817486
   PubMed Web of Science ®Google Scholar
• Duraes AR, Roriz PD, Bulhoes FV, et al. Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively protocol. JMIR Res Protoc. 2014;3:e21. doi:10.2196/resprot.301424691436
   PubMedGoogle Scholar
• Lee MT, Klein TE. Pharmacogenetics of warfarin. challenges and opportunities. J Hum Genet. 2013;58:334–338. doi:10.1038/jhg.2013.4023657428
   PubMed Web of Science ®Google Scholar
• Self TH, Wallace JL, Sakaan S, Sands CW. Effect of body weight on dose of Vitamin K antagonists. South Med J. 2015;108:637–643. doi:10.14423/SMJ.000000000000035626437201
   PubMed Web of Science ®Google Scholar
• Johnson JA. Warfarin: an old drug but still interesting. Pharmacotherapy. 2008;28:1081–1083. doi:10.1592/phco.28.9.108118752378
   PubMed Web of Science ®Google Scholar
• Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature. 2004;427:541–544. doi:10.1038/nature0225414765195
   PubMed Web of Science ®Google Scholar
• Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 2004;427:537–541. doi:10.1038/nature0221414765194
   PubMed Web of Science ®Google Scholar
• Johnson JA, Caudle KE, Gong L, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing. 2017 update. Clin Pharmacol Ther. 2017;102:397–404. doi:10.1002/cpt.66828198005
   PubMed Web of Science ®Google Scholar
• Yin T, Miyata T. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 –rationale and perspectives. Thromb Res. 2007;120:1–10. doi:10.1016/j.thromres.2006.10.02117161452
   PubMed Web of Science ®Google Scholar
• Watzka M, Geisen C, Bevans CG, et al. Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. J Thromb Haemost. 2011;9:109–118. doi:10.1111/j.1538-7836.2010.04095.x20946155
   PubMed Web of Science ®Google Scholar
• Lee MT, Chen CH, Chuang HP, et al. VKORC1 haplotypes in five East-Asian populations and Indians. Pharmacogenomics. 2009;10:1609–1616. doi:10.2217/pgs.09.8019842934
   PubMed Web of Science ®Google Scholar
• Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med. 2005;352:2285–2293. doi:10.1056/NEJMoa04450315930419
   PubMed Web of Science ®Google Scholar
• Geisen C, Watzka M, Sittinger K, et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost. 2005;94:773–779. doi:10.1160/TH05-04-029016270629
   PubMed Web of Science ®Google Scholar
• Ensembl genome browser. Available at: www.Ensembl.org. Accessed September 10, 2018.
   Google Scholar
• PharmGKB. Pharmacogenomics Database. Available at: www.Pharmgkb.org. Accessed September 10, 2018.
   Google Scholar
• Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928–1929. doi:10.1093/bioinformatics/btl26816720584
   PubMed Web of Science ®Google Scholar
• dynacom. SNPAlyze Ver.9.0. Available from: https://www.dynacom.co.jp/english/snpalyze_e/e_sa_demo.html. Accessed August 8, 2018.
   Google Scholar
• Garcia-Bertrand R, Simms TM, Cadenas AM, Herrera RJ. United Arab Emirates: phylogenetic relationships and ancestral populations. Gene. 2014;533:411–419. doi:10.1016/j.gene.2013.09.09224120897
   PubMed Web of Science ®Google Scholar
• Al-Gazali LI. Attitudes toward genetic counseling in the United Arab Emirates. Community Genet. 2005;8:48–51. doi:10.1159/00008333915767756
   PubMedGoogle Scholar
• John SE, Antony D, Eaaswarkanth M, et al. Genetic variants associated with warfarin dosage in Kuwaiti population. Phagmacogenomics. 2017;8:757–764. doi:10.2217/pgs-2017-0020
   Web of Science ®Google Scholar
• Limdi NA, Wadelius M, Cavallari L, et al. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood. 2010;115:3827–3834. doi:10.1182/blood-2009-12-25599220203262
   PubMed Web of Science ®Google Scholar
• Alzahrani AM, Ragia G, Hania H, Manolopoulos VG. Genotyping of CYP2C9 and VKORC1 in the Arabic Population of Al-Ahsa, Saudi Arabia. Biomed Res Int. 2013;2013:315890.
   Google Scholar
• Owen RP, Gong L, Sagreiya H, Klein TE, Altman RB. VKORC1 pharmacogenomics summary. Pharmacogenet Genomics. 2010;20:642–644. doi:10.1097/FPC.0b013e32833433b619940803
   PubMed Web of Science ®Google Scholar
• Wadelius M, Chen LY, Downes K, et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J. 2005;5:262–270. doi:10.1038/sj.tpj.650031315883587
   PubMed Web of Science ®Google Scholar
• Jia L, Wang Z, Men J, Cai H, Wei M. Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population. Ther Clin Risk Manag. 2017;13:421–425.28408837
   PubMed Web of Science ®Google Scholar
• Cavallari LH, Langaee TY, Momary KM, et al. Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther. 2010;87:459–464. doi:10.1038/clpt.2009.22320072124
   PubMed Web of Science ®Google Scholar
• Veenstra DL, You JH, Rieder MJ, et al. Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenet Genomics. 2015;15:687–691. doi:10.1097/01.fpc.0000174789.77614.68
   Web of Science ®Google Scholar
• Namazi S, Azarpira N, Hendijani F, Khorshid MB, Vessal G, Mehdipour AR. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements. A cross-sectional study in Iran. Clin Ther. 2010;32:1050–1060. doi:10.1016/j.clinthera.2010.06.01020637959
   PubMed Web of Science ®Google Scholar
• Pathare A, Al Khabori M, Alkindi S, et al. Warfarin pharmacogenetics. development of a dosing algorithm for Omani patients. J Hum Genet. 2012;57:665–669. doi:10.1038/jhg.2012.9422854539
   PubMed Web of Science ®Google Scholar
• D’Andrea G, D’Ambrosio RL, Di Perna P, et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 2005;105:645–649. doi:10.1182/blood-2004-06-211115358623
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Ding J. VKORC1 −1639G/A and 1173 C/T genetic polymorphisms influence individual differences in warfarin maintenance dose. Genet Test Mol Biomarkers. 2015;19:488–493. doi:10.1089/gtmb.2015.009726167638
   PubMed Web of Science ®Google Scholar
• Perera MA, Gamazon E, Cavallari LH, et al. The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Clin Pharmacol Ther. 2011;89:408–415. doi:10.1038/clpt.2010.32221270790
   PubMed Web of Science ®Google Scholar
• Shrif NE, Won HH, Lee ST, et al. Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients. Eur J Clin Pharmacol. 2011;67:1119–1130. doi:10.1007/s00228-011-1060-121590310
   PubMed Web of Science ®Google Scholar
• Scott SA, Edelmann L, Kornreich R, Desnick RJ. Warfarin pharmacogenetics. CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations. Am J Hum Genet. 2008;82:495–500. doi:10.1016/j.ajhg.2007.10.00218252229
   PubMed Web of Science ®Google Scholar
• Aklillu E, Leong C, Loebstein R, Halkin H, Gak E. VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals. Blood. 2008;111:3903–3904. doi:10.1182/blood-2008-01-13586318362220
   PubMed Web of Science ®Google Scholar
• Kurnik D, Qasim H, Sominsky S, et al. Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction. Thromb Haemost. 2012;108:781–788. doi:10.1160/TH12-03-015122871975
   PubMed Web of Science ®Google Scholar
• Slatkin M. Linkage disequilibrium – understanding the evolutionary past and mapping the medical future. Nat Rev Genet. 2008;9:477–485. doi:10.1038/nrg236118427557
   PubMed Web of Science ®Google Scholar
• Takeuchi F, Yanai K, Morii T, et al. Linkage disequilibrium grouping of Single Nucleotide Polymorphisms (SNPs) reflecting haplotype phylogeny for efficient selection of tag SNPs. Genetics. 2005;70:291–304. doi:10.1534/genetics.104.038232
   Web of Science ®Google Scholar
• Neidecker M, Patel AA, Nelson WW, Reardon G. Use of warfarin in long-term care. A systematic review. BMC Geriatr. 2012;12:14. doi:10.1186/1471-2318-12-1422480376
   PubMed Web of Science ®Google Scholar